Literature DB >> 2311169

The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.

L M Wang1, J C White, R L Capizzi.   

Abstract

The cytotoxicity of ara-C is believed to result from incorporation of ara-CTP into DNA and inhibition of DNA synthesis. Since complete inhibition of DNA synthesis would prevent further incorporation of ara-CTP, ara-C may have a self-limiting effect on its own cytotoxicity, particularly at the high concentrations typical of high-dose ara-C clinical protocols. In this study, the incorporation of [3H]-dThd and [3H]-ara-C into DNA were compared. Within 1 h of exposure of L5178Y cells to ara-C, the rate of [3H]-dThd incorporation into the acid-insoluble fraction was reduced by 98%. Despite this nearly complete block in [3H]-dThd incorporation, DNA synthesis was not completely inhibited since [3H]-ara-C continued to be incorporated for up to 6 h, although a plateau in ara-CDNA synthesis was observed between 2 and 3 h exposure when ara-CTP levels were maximal. The effect of ara-C on [3H]-dThd incorporation into DNA was due in part to an indirect effect of ara-C on the metabolism of intracellular [3H]-dThd to [3H]-dTTP. Within 30 min exposure to 10 microM ara-C, the rate of cellular [3H]-dTTP synthesis was slowed to only 15% of the control rate. This was not due to inhibition of [3H]-dThd transport, since the intracellular and extracellular concentrations of the nucleoside were equal. The effect of ara-C on [3H]-dTTP synthesis resulted from significant changes in deoxynucleoside 5'-triphosphate (dNTP) pools. dTTP, dATP, and dGTP levels were increased, whereas the dCTP concentration was decreased. When dThd kinase from L5178Y cells was assayed with increased dTTP levels induced by ara-C vs the dTTP level in control cells, its activity was reduced by 72%. Thus, the [3H]-dThd incorporation experiment overestimated the extent of inhibition of DNA synthesis by ara-C due to increased feedback inhibition of dThd kinase and increased competition for DNA polymerase between the elevated unlabeled dTTP pool and the decreased levels of [3H]-dTTP. In vitro assay of DNA polymerase in the presence of the ara-CTP concentration achieved after 0.5 or 3 h exposure to 10 microM ara-C (60 microM and 200 microM, respectively), plus the mixture of dNTPs found intracellularly at these times, resulted in 57% and 80% inhibition of the polymerase, respectively. This inhibition may account for the plateau in the accumulation of ara-CDNA that was observed at 3 h and suggests that ara-C incorporation may be self-limiting at high cellular concentrations of ara-CTP.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311169     DOI: 10.1007/bf00686052

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  23 in total

1.  Allosteric regulation of calf thymus ribonucleoside diphosphate reductase.

Authors:  S Eriksson; L Thelander; M Akerman
Journal:  Biochemistry       Date:  1979-07-10       Impact factor: 3.162

Review 2.  Advances in the treatment of acute myelogenous leukemia.

Authors:  R P Gale
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

3.  A rapid assay for CDP reductase activity in mammalian cell extracts.

Authors:  J R Steeper; C D Steuart
Journal:  Anal Biochem       Date:  1970-03       Impact factor: 3.365

4.  Deoxycytidine kinase. 3. Kinetics and allosteric regulation of the calf thymus enzyme.

Authors:  D H Ives; J P Durham
Journal:  J Biol Chem       Date:  1970-05-10       Impact factor: 5.157

5.  RNA dependent DNA polymerase activity in mammalian cells.

Authors:  E M Scolnick; S A Aaronson; G J Todaro; W P Parks
Journal:  Nature       Date:  1971-01-29       Impact factor: 49.962

6.  Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells.

Authors:  J C White; J P Rathmell; R L Capizzi
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

7.  Continuous infusion high-dose cytosine arabinoside in refractory childhood leukemia.

Authors:  J Ochs; J A Sinkule; M K Danks; A T Look; W P Bowman; G Rivera
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

8.  Lethality of human myeloblasts correlates with the incorporation of arabinofuranosylcytosine into DNA.

Authors:  P P Major; E M Egan; G P Beardsley; M D Minden; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

9.  Prediction of therapeutic response in acute leukaemia.

Authors:  P C Raich
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

10.  Effect of uracil arabinoside on metabolism and cytotoxicity of cytosine arabinoside in L5178Y murine leukemia.

Authors:  J L Yang; E H Cheng; R L Capizzi; Y C Cheng; T Kute
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

View more
  5 in total

1.  Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.

Authors:  Ping Chen; Josephine Aimiuwu; Zhiliang Xie; Xiaohui Wei; Shujun Liu; Rebecca Klisovic; Guido Marcucci; Kenneth K Chan
Journal:  AAPS J       Date:  2010-12-30       Impact factor: 4.009

2.  The antimetabolite ara-CTP blocks long-term memory of conditioned taste aversion.

Authors:  Jianpeng Wang; Keqin Ren; Javier Pérez; Alcino J Silva; Sandra Peña de Ortiz
Journal:  Learn Mem       Date:  2003 Nov-Dec       Impact factor: 2.460

3.  Superresolution imaging of individual replication forks reveals unexpected prodrug resistance mechanism.

Authors:  Therese Triemer; Alessandra Messikommer; Stella M K Glasauer; Jawad Alzeer; Miriam H Paulisch; Nathan W Luedtke
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-29       Impact factor: 11.205

4.  Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.

Authors:  T Yamauchi; Y Kawai; N Goto; S Kishi; S Imamura; A Yoshida; Y Urasaki; T Fukushima; H Iwasaki; H Tsutani; M Masada; T Ueda
Journal:  Jpn J Cancer Res       Date:  2001-09

5.  Modulation of the effect of 1-beta-D-arabinofuranosylcytosine by 6-mercaptopurine in L1210 cells.

Authors:  Y Kawai; T Ueda; T Nakamura
Journal:  Jpn J Cancer Res       Date:  1994-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.